Icatibant Acetate API Market
Icatibant Acetate API Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Icatibant Acetate API Market Size and Growth
The Icatibant Acetate API market is experiencing steady growth, driven by rising demand for bradykinin receptor antagonists in treating hereditary angioedema. Current market size is estimated at approximately $200 million, with projections indicating significant expansion due to increased awareness, research advancements, and potential new therapeutic applications in the pharmaceutical industry. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Dr. Reddy’s Laboratories Ltd.
◍ ChemWerth Inc
◍ Bachem AG
The Icatibant Acetate API market features companies like Dr. Reddy’s Laboratories, ChemWerth, Bachem, Biophore, Tecoland, Teva API, and Sun Pharmaceutical, which manufacture and sell APIs to support treatment for hereditary angioedema. Their expertise enhances market growth through innovation, strategic partnerships, and expanding distribution channels.
◍ Biophore India Pharmaceuticals Pvt. Ltd.
◍ Tecoland Corporation
◍ Teva API
◍ Sun Pharmaceutical Industries Ltd.
Sales revenue figures:
- Dr. Reddy’s Laboratories: $2.2 billion
- Sun Pharmaceutical Industries: $4.5 billion
- Teva API: $16.7 billion Request Sample Report
Market Segmentation
By Application
◍ Icatibant Acetate Injections
◍ Others
By Product
◍ Purity≥98%
◍ Purity<98%
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
